3/16
06:54 pm
rgen
A Look Back at Drug Development Inputs & Services Stocks' Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack [Yahoo! Finance]
Neutral
Report
A Look Back at Drug Development Inputs & Services Stocks' Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack [Yahoo! Finance]
3/13
06:16 am
rgen
2 Growth Stocks Set to Flourishand 1 We Turn Down [Yahoo! Finance]
Low
Report
2 Growth Stocks Set to Flourishand 1 We Turn Down [Yahoo! Finance]
3/10
02:26 pm
rgen
Repligen Corporation (RGEN) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
Repligen Corporation (RGEN) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/8
11:36 pm
rgen
Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns [Yahoo! Finance]
Medium
Report
Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns [Yahoo! Finance]
3/8
09:39 pm
rgen
Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals [Yahoo! Finance]
Medium
Report
Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals [Yahoo! Finance]
3/5
08:08 am
rgen
Repligen Corporation to Present at Upcoming March Conferences [Yahoo! Finance]
Low
Report
Repligen Corporation to Present at Upcoming March Conferences [Yahoo! Finance]
3/5
07:30 am
rgen
Repligen Corporation to Present at Upcoming March Conferences
Low
Report
Repligen Corporation to Present at Upcoming March Conferences
3/5
06:01 am
rgen
Repligen (RGEN) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d+)".
Low
Report
Repligen (RGEN) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d+)".
3/3
10:03 am
rgen
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead [Yahoo! Finance]
2/25
03:40 pm
rgen
Repligen (RGEN) had its price target lowered by UBS Group AG from $200.00 to $195.00. They now have a "buy" rating on the stock.
Low
Report
Repligen (RGEN) had its price target lowered by UBS Group AG from $200.00 to $195.00. They now have a "buy" rating on the stock.
2/25
11:32 am
rgen
Repligen (RGEN) had its price target lowered by Barclays PLC from $200.00 to $175.00. They now have an "overweight" rating on the stock.
Low
Report
Repligen (RGEN) had its price target lowered by Barclays PLC from $200.00 to $175.00. They now have an "overweight" rating on the stock.
2/25
10:24 am
rgen
Repligen (RGEN) had its price target lowered by Wells Fargo & Company from $190.00 to $180.00. They now have an "overweight" rating on the stock.
Low
Report
Repligen (RGEN) had its price target lowered by Wells Fargo & Company from $190.00 to $180.00. They now have an "overweight" rating on the stock.
2/25
10:07 am
rgen
Repligen (RGEN) had its "overweight" rating reaffirmed by KeyCorp.
Low
Report
Repligen (RGEN) had its "overweight" rating reaffirmed by KeyCorp.
2/25
09:40 am
rgen
How The Repligen (RGEN) Narrative Is Shifting With New Targets M&A Plans And Products [Yahoo! Finance]
Low
Report
How The Repligen (RGEN) Narrative Is Shifting With New Targets M&A Plans And Products [Yahoo! Finance]
2/24
01:06 pm
rgen
Repligen Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Repligen Q4 Earnings Call Highlights [Yahoo! Finance]
2/24
10:32 am
rgen
Repligen (RGEN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Repligen (RGEN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/24
07:57 am
rgen
Repligen (NASDAQ:RGEN) Exceeds Q4 CY2025 Expectations [Yahoo! Finance]
Low
Report
Repligen (NASDAQ:RGEN) Exceeds Q4 CY2025 Expectations [Yahoo! Finance]
2/24
07:51 am
rgen
Repligen: Q4 Earnings Snapshot [Yahoo! Finance]
Low
Report
Repligen: Q4 Earnings Snapshot [Yahoo! Finance]
2/24
07:30 am
rgen
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Low
Report
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
2/22
10:22 pm
rgen
Repligen (RGEN) To Report Earnings Tomorrow: Here Is What To Expect [Yahoo! Finance]
Low
Report
Repligen (RGEN) To Report Earnings Tomorrow: Here Is What To Expect [Yahoo! Finance]
2/19
07:57 am
rgen
Repligen Corp. (RGEN) Rose as Industrial Destocking Decreased and Order Patterns Stabilized [Yahoo! Finance]
Low
Report
Repligen Corp. (RGEN) Rose as Industrial Destocking Decreased and Order Patterns Stabilized [Yahoo! Finance]
2/18
06:38 pm
rgen
Repligen (NASDAQ:RGEN) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
Low
Report
Repligen (NASDAQ:RGEN) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
2/10
07:30 am
rgen
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results
2/4
08:26 pm
rgen
A Look At Repligen (RGEN) Valuation As Ordering Stabilizes And Growth Segments Progress [Yahoo! Finance]
Medium
Report
A Look At Repligen (RGEN) Valuation As Ordering Stabilizes And Growth Segments Progress [Yahoo! Finance]
2/3
04:47 am
rgen
3 Volatile Stocks Walking a Fine Line [Yahoo! Finance]
Low
Report
3 Volatile Stocks Walking a Fine Line [Yahoo! Finance]